AVALO THERAPEUTICS INC (AVTX)

US05338F3064 - Common Stock

14.9  -0.85 (-5.4%)

After market: 16 +1.1 (+7.38%)

News Image
13 days ago - Chartmill

Tuesday's pre-market session: top gainers and losers

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

News Image
13 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to check out all of the biggest pre-market stock movers worth watching on with the winners and losers of Tuesday!

News Image
13 days ago - Avalo Therapeutics

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent DirectorsBoard of Director appointments in...

News Image
14 days ago - Chartmill

Curious about the stocks that are showing activity after the closing bell on Monday?

After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

News Image
14 days ago - Chartmill

Which stocks have an unusual volume on Monday?

In today's session, these stocks are experiencing unusual volume.

News Image
14 days ago - Chartmill

These stocks are moving in today's session

Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.

News Image
14 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning!

News Image
17 days ago - Avalo Therapeutics

Avalo Reports 2023 Financial Results and Provides Business Updates

Acquired AVTX-009, Phase-2 ready anti-IL-1β mAb, in March 2024Increased cash position with private placement financing in March 2024 providing up to $185...

News Image
18 days ago - InvestorPlace

Why Is Urban-gro (UGRO) Stock Down 18% Today?

Urban-gro stock is falling on Thursday as UGRO investors react to the company's lackluster earnings report for the fourth quarter of 2023.

News Image
18 days ago - InvestorPlace

Why Is Binah Capital (BCG) Stock Up 93% Today?

Binah Capital stock is on the rise Thursday as BCG shares experience heavy trading following the company's public debut yesterday.

News Image
18 days ago - InvestorPlace

Why Is Avalo Therapeutics (AVTX) Stock Up 326% Today?

Avalo Therapeutics stock is up with heavy trading of AVTX shares are completing its acquisition of AlmataBio and securing new funding.

News Image
18 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are a hot topic on Thursday as we check out all of the biggest stories moving shares this morning!

News Image
19 days ago - Avalo Therapeutics

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million

Avalo acquires Phase 2-ready anti-IL-1β mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!

News Image
4 months ago - Seeking Alpha

Avalo Therapeutics announces a 1-for-240 reverse stock split

Avalo Therapeutics (AVTX) board has approved a 1-for-240 reverse stock split that will become effective with the commencement of trading on December 29, 2023. The reverse stock split is part

News Image
4 months ago - Avalo Therapeutics

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 reverse stock split...